+ Watch TROV
on My Watchlist
New Diagnostic tests for cancer.
Cheaper than blood tests or traditional tests, and their validation tests of the technology have been positive thus far
This is biotech at an early research stage, but a very interesting play. Imagine screening for various diseases and cancer all with a simple urine test. No more blood work and no more needles.As with all biotechs -- if* they get this right, they are gonna make a lot of money
A stock that went public at as low a price as this did is probably garbage. Book value of only 35 cents. No, thank you.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions